TB-500 Addition TB-500 (Thymosin Beta-4) enhances tissue regeneration, cell migration, and angiogenesis, with typical blend ratios of 5:1:1 (GHK-Cu:TB-500:BPC-157)
Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
LipLixir: A natural lip balm offering a safer alternative to conventional products, free of harmful ingredients like synthetic dyes and fragrances
If you are satisfied with 3.33 mg/mL, stick with 3.33 mg/mL for every vial
The last approach that is rarely used by us nowadays is the interlaminar approach, which places the injection directly into the central canal between two vertebrae
